Evidence map›Paper›PMID 42246608›Full record

ArticleBritish journal of haematology2026

Machine learning-driven investigation on liquid-liquid phase separation-related prognostic signature in diffuse large B-cell lymphoma.

Zhen-Zhong Zhou, Jia-Chen Lu, Zhao Wang, Rong-Hui Chen, Hai-Long Li, Wan-Ting Chen, Yu-Ning Deng, Hui-Juan Zhang, Yu Wang, Xuan-Ye Zhang and 2 more

Abstract read
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhen-Zhong ZhouDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jia-Chen LuDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhao WangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Rong-Hui ChenDepartment of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, P. R. China.
Hai-Long LiDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wan-Ting ChenDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yu-Ning DengDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hui-Juan ZhangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yu WangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xuan-Ye ZhangDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wei-Juan HuangDepartment of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, P. R. China.
Xiao-Peng TianDepartment of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.ORCID https://orcid.org/0000-0003-4601-3475

Funding

Guangdong Basic and Applied Basic Research Foundation 2024A1515010185Guangdong Basic and Applied Basic Research Foundation 2024B1515020026National Natural Science Foundation of China 82370190National Natural Science Foundation of China 82422010National Natural Science Foundation of China 82574486
6 · The paper itself

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma and is characterized by substantial heterogeneity. This study aimed to develop a liquid-liquid phase separation (LLPS)-related prognostic model to improve risk stratification. Transcriptomic and clinical data from four cohorts (n = 768) were analysed. Multiple machine learning algorithms were applied to identify prognostic LLPS-related genes (LRGs) and construct a 6-LRG model. Model performance was assessed using survival analysis, time-dependent receiver operating characteristic curves and multivariable modelling. Additional analyses were conducted to explore potential biological and microenvironmental differences between risk groups. The 6-LRG model stratified patients into groups with significantly different overall survival across datasets, with 1-year area under curve (AUCs) ranging from 0.661 to 0.820, 3-year AUCs from 0.683 to 0.779 and 5-year AUCs from 0.711 to 0.807. The 6-LRG model remained independent of established clinical variables and improved risk prediction when integrated into a nomogram. Distinct biological and immune characteristics were observed between groups. The 6-LRG model may provide additional prognostic information in DLBCL and generates hypotheses regarding underlying biological mechanisms. However, prospective validation in larger populations is essential before any implementation.

Indexed as

Lymphoma, Large B-Cell, DiffuseMachine LearningFemaleHumansMaleMiddle AgedPhase SeparationPredictive Learning ModelsPrognosisdiffuse large B‐cell lymphomaimmune environmentliquid–liquid phase separationprognostic biomarkerprognostic model

Identifiers

PMID42246608
PMCPMC13461964

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.